Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
NCT00004858
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
OTHER
Sponsor class
Conditions
Leukemia
Lymphoma
Interventions
BIOLOGICAL:
B43-genistein immunoconjugate
Sponsor
Parker Hughes Cancer Center